We are live on ! Find out more
NC

Nekton Capital Portfolio holdings

AUM $49.4M
1-Year Est. Return 2.45%
This Fund
S&P 500
This Quarter Est. Return
+3.5%
1 Year Est. Return
-2.45%
3 Year Est. Return
+30.15%
5 Year Est. Return
10 Year Est. Return
AUM
$610M
AUM Growth
+$10.9M
Cap. Flow
-$5.69M
Cap. Flow %
-0.93%
Top 10 Hldgs %
82.98%
Holding
22
New
7
Increased
3
Reduced
4
Closed
7

Top Buys

Rank Stock Value
1
BDX icon
Becton Dickinson
BDX
+$79.3M
2
EXC icon
Exelon
EXC
+$40.4M
3
TECK icon
Teck Resources
TECK
+$32.6M
4
ACI icon
Albertsons Companies
ACI
+$27.7M
5
HEI.A icon
HEICO Corp Class A
HEI.A
+$21.6M

Sector Composition

Rank Sector Weight
1 Healthcare 40.77%
2 Industrials 27.98%
3 Consumer Staples 12.23%
4 Utilities 6.52%
5 Technology 5.79%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
BDX icon
1
Becton Dickinson
BDX
$48.6B
$82.4M 13.5%
+312,148
New +$79.3M
QGEN icon
2
Qiagen
QGEN
$8.57B
$78.1M 12.79%
1,634,690
-46,681
-3% -$2.25M
ALC icon
3
Alcon
ALC
$33.8B
$58.1M 9.52%
707,175
-259,267
-27% -$19.8M
UNP icon
4
Union Pacific
UNP
$175B
$57.9M 9.49%
283,055
+82,849
+41% +$16.5M
EMR icon
5
Emerson Electric
EMR
$87.4B
$52.8M 8.65%
584,133
+243,137
+71% +$20.5M
EXC icon
6
Exelon
EXC
$46.7B
$39.8M 6.52%
+976,461
New +$40.4M
J icon
7
Jacobs Solutions
J
$16.8B
$37.3M 6.11%
379,445
PTC icon
8
PTC
PTC
$16B
$35.4M 5.79%
248,505
+30,031
+14% +$3.98M
CL icon
9
Colgate-Palmolive
CL
$73.7B
$32.7M 5.36%
424,574
-259,312
-38% -$20.1M
TECK icon
10
Teck Resources
TECK
$32.4B
$31.9M 5.23%
+758,796
New +$32.6M
HZNP
11
DELISTED
Horizon Therapeutics Public Limited Company Ordinary Shares
HZNP
$30.2M 4.96%
294,015
-223,740
-43% -$23.6M
ACI icon
12
Albertsons Companies
ACI
$5.84B
$29.1M 4.76%
+1,332,181
New +$27.7M
HEI.A icon
13
HEICO Corp Class A
HEI.A
$36.7B
$22.7M 3.72%
+161,407
New +$21.6M
EL icon
14
Estee Lauder
EL
$30.8B
$12.8M 2.1%
+65,394
New +$13.9M
HTHT icon
15
Huazhu Hotels Group
HTHT
$13.2B
$9.04M 1.48%
+233,093
New +$10.1M
BAM icon
16
Brookfield Asset Management
BAM
$84.5B
-817,174
Closed -$26.7M
BNY
17
Bank of New York Mellon
BNY
$107B
-577,350
Closed -$26.2M
BN icon
18
Brookfield
BN
$108B
-774,956
Closed -$16.8M
CME icon
19
CME Group
CME
$94.7B
-129,765
Closed -$24.9M
DG icon
20
Dollar General
DG
$28B
-156,671
Closed -$33M
NATI
21
DELISTED
National Instruments Corp
NATI
-932,419
Closed -$48.9M
SJR
22
DELISTED
Shaw Communications Inc.
SJR
-1,002,063
Closed -$30M

Similar funds

Nekton Capital's Q2 2023 Portfolio in Review

As of Q2 2023, Nekton Capital held 22 positions worth $610M, up 1.8% from $599M the previous quarter. Its ten largest holdings account for 83% of the portfolio.

Nekton Capital's Q2 2023 filing shows 7 new, 3 increased, 4 reduced and 7 closed positions. Its largest new stake was Becton Dickinson: 312,148 shares worth $82.4M. The largest sale was National Instruments Corp, an estimated $48.9M.

By sector, the portfolio is most concentrated in Healthcare at 41% of assets, up from 34% a quarter earlier, followed by Industrials and Consumer Staples.

  • Nekton Capital's largest Q2 2023 buy was Becton Dickinson: 312,148 shares worth $82.4M.
  • Nekton Capital added most to Emerson Electric in Q2 2023, an estimated $20.5M increase.
  • Nekton Capital's biggest Q2 2023 reduction was Horizon Therapeutics Public Limited Company Ordinary Shares, cutting an estimated $23.6M.
  • Nekton Capital fully exited National Instruments Corp in Q2 2023, selling an estimated $48.9M.
  • Nekton Capital's ten largest holdings make up 83% of its $610M portfolio in Q2 2023.
  • Nekton Capital opened 7 new positions and closed 7 in Q2 2023.
  • Nekton Capital's portfolio value rose 1.8% quarter-over-quarter to $610M.

Based on Nekton Capital's 13F filing for Q2 2023, filed 14 Aug 2023.